15:59 Feb 25

Wockhardt Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1377.10
+15.10 (+1.11%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Wockhardt Ltd. Financials

Wockhardt Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1377.10
+15.10 (+1.11%)
15:59 Feb 25
Quality
image/svg+xml

52/100
Medium Financial Strength

Valuation
image/svg+xml

24/100
Expensive Valuation

Technical

36/100
Technically Neutral

Strength

9

Weakness

3

Opportunity

0

Threats

1

-1.07 %

ROE %

-0.57 %

ROA %

1.35

EPS

268.70

BVPS

-1.56 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
2708.3 3230 2651 2798 3012
Operating Expenses +
2771.33 2932 2550 2759 2619
Raw Material
1262.33 1180 1027 1179 1185
Increase Decrease in Cost
-126.84 87 84 -14 -53
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
762.95 749 637 629 651
Miscellaneous Expenses
2032.69 2052 1820 2083 1982
Operating Profit
-63.03 298 101 39 393
Other Income
132.27 20 122 83 62
Depreciation
246.02 247 251 223 217
Interest
249.08 299 302 305 254
Profit before tax and exceptio..
-425.86 -228 -330 -406 -16
Exceptional Items
1327.84 -183 -294 -14 0
PBT
901.98 -411 -624 -420 -16
Provision for Taxation
-271.61 -132 -3 52 41
Net Profit
688.6 -279 -621 -472 -57
NET Profit after MI
686.06 -244 -559 -463 -47
EPS
61.68 -20.24 -38.79 -32.05 -3.02
Operating Profit Margin (%)
-2.33 9.23 3.81 1.39 13.05
Net Profit Margin (%)
25.33 -7.55 -21.09 -16.55 -1.56

Wockhardt Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 49.10 49.10 49.10 49.10 49.10 52.00
FII 7.00 7.10 7.30 6.80 6.50 6.70
Public 10.60 11.00 11.00 10.60 9.90 5.10
Others 33.30 32.80 32.60 33.50 34.50 36.20
Shareholder Shares Holding %
Download Our App On: